In the first half of 2020, the pandemic spurred a surge in the use of telemedicine and other virtual medical services — as well as a flurry of related regulatory changes — that might have otherwise taken years.
That swell has corresponded with an uptick in spending on federal lobbying by some telemedicine and other health tech companies and the trade groups that represent them, according to a STAT review of federal filings updated this week.
About the Author Reprints
